Clinical Perinatal Software Market

Global Oligonucleotide Synthesis Market research report delivers a comprehensive analysis of the market outlook, regulatory framework, and macro- and micro-economic factors influencing the growth of the market. The report is formulated through extensive research and surveys to offer accurate and authentic information about the market size, market share, product portfolio, revenue generation, and projected market growth.

The report offers key insights into the competitive and regional landscape of the market to assist the stakeholders and investors in formulating strategic business plans.  The global Oligonucleotide Synthesis Market is forecasted to be worth USD 9.91 Billion by 2027, according to a current analysis by Emergen Research.  The rapid growth of the global market for oligonucleotide synthesis can be attributed to the growing demand for advanced therapeutic procedures.

Besides, the rising research activities in the pharmaceutical and biotechnology industry is expected to drive the market growth further. Moreover, the increasing applications of synthesized oligonucleotides are also likely to augment the market growth over the forecasted timeline.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/351

The report also assesses the current market scenario of the Oligonucleotide Synthesis Market business sector with regard to the impact of the COVID-19 pandemic on the market. The report is furnished with the current details and changes in the demand and trends relating to the COVID-19 crisis. The pandemic has brought dynamic changes in the major segments of the market. The report covers the present and future impact of the COVID-19 crisis and offers insights into the post-COVID-19 economic scenario.

Leading Players Analyzed in the Report are:

GeneDesign, Inc., Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc., Bio-Synthesis, Inc., Agilent Technologies, Inc., Biogen Idec International GmbH, Nitto Denko Avecia, Inc., ATDBio Ltd, Integrated DNA Technologies, Inc., and GenScript, Inc. among others.

The lack of standardized regulations for the safe use of synthesized oligonucleotide is anticipated to hinder the market growth during the forecasted period.

Some Key Highlights from the Report

  • In the forecast timeframe, the research segment is anticipated to dominate the market with CAGR of 13.0%. The increase in the number of genome research projects undertaken by academic research institutes facilitated the dominant market position in this segment.
  • North America is forecasted to be the largest market over the forecast timeframe, mainly due to the growing research & development activities and the increasing amount of oligos-based diagnoses and treatments being approved by food and drug administration.
  • In May 2020, Integrated DNA Technologies, a leading producer of integrated genomics solutions, has announced the opening of a new production facility located in North Carolina’s Research Triangle Park. The plant extends the production capacity of IDT and will provide the east section of the United States with industry-leading turnaround times for its product range. Integrated DNA Technologies also planned the North Carolina plant for the first development of goods in response to the COVID-19 epidemic to aid its clients’ activities related to COVID-19 analysis and testing.
  • The largest market is expected to be held by the hospital segment. The high number of inpatient and outpatient hospitalizations combined with the growing requirement for oligonucleotide drugs drives the market growth in the segment to meet the needs of the vast number of people suffering from chronic diseases.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/351

Emergen Research has segmented the global Oligonucleotide Synthesis Market on the basis of product, application, end-use, and region:

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Therapeutic
  • Research
  • Diagnostics

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Linkers
  • Synthesized Oligonucleotides
  • Equipment
  • Probe
  • Adaptor
  • Reagent

End-Use Outlook (Revenue, USD Billion; 2017-2027)

  • Pharmaceutical
  • Hospitals
  • Biotechnology
  • Laboratories

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/oligonucleotide-synthesis-market

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA

Key points covered in the report:

  • In-depth analysis of the historical years (2017-2018) and forecast period (2020-2027)
  • A detailed outlook of the market with essential data beneficial for business
  • Market segmentation based on product types, applications, and end-users. For further understanding, the key segments are further divided into sub-segments
  • Growth factors, driving and restraining factors, product trends, and technological advancements are extensively discussed
  • Latest product developments, incorporation of new techniques and profiles of major competitors
  • An 8-year forecast estimation detailing the growth and expansion scope of the Oligonucleotide Synthesis Market
  • Market dynamics with information of players, challenges, restraints, threats, and opportunities
  • SWOT analysis and Porter’s Five Forces analysis of the top vendors

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/351

Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiries, and we will ensure you get the report best suited for your needs.

About Emergen Research 

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a ‘Circular Economy,’ fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkedIn | Twitter | Blogs

Browse More Similar Reports:

Artificial Intelligence (AI) In Radiology Market: https://www.emergenresearch.com/industry-report/artificial-intelligence-in-radiology-market

Electronic Medical Records Market: https://www.emergenresearch.com/industry-report/electronic-medical-records-market

Predictive Biomarkers Market: https://www.emergenresearch.com/industry-report/predictive-biomarkers-market

Smart Stethoscope Market: https://www.emergenresearch.com/industry-report/smart-stethoscope-market

Human Microbiome Market: https://www.emergenresearch.com/industry-report/human-microbiome-market

Leave a Reply

Your email address will not be published.